A new study by the University of Bangor in North Wales has found that the British public do not support England’s Cancer Drugs Fund. The study asked over 4,000 people across England, Wales and Scotland if the NHS should pay extra for cancer drugs in comparison to medication for equally serious conditions. The majority of
Drugs developed to treat rare diseases have the potential to produce as much lifetime revenue as medication used for more common health conditions, according to a study published by Thomson Reuters yesterday. The report compared the total value of orphan drugs from 1990 to 2030 and found that government incentives, shorter clinical trials and high
According to a study in Sweden, people who have developed Huntington’s disease, a debilitating brain condition, appear have a “protection” from cancer. The findings, which were published in The Lancet Oncology, analysed almost 40 years of medical records, showing that patients with Huntington’s have half the normal expected risk of developing tumours. However researchers commented
